Sodium reabsorption in the thick ascending limb in relation to blood pressure: A clinical perspective

Hypertension

Volumn 57, Issue 5, 2011, Pages 873-879

  Jung, Jeesun ^a   Basile, David P ^a   Pratt, J Howard ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ALDOSTERONE; AMILORIDE; ANGIOTENSIN II; CALCIUM ION; CALCIUM SENSING RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 4A11; ELECTROLYTE; ENDOTHELIN; EPITHELIAL SODIUM CHANNEL; FUROSEMIDE; MAGNESIUM ION; PROSTAGLANDIN; SODIUM; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SUPEROXIDE; VASOPRESSIN;

ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; ARTERIOLE; BARTTER SYNDROME; BLOOD PRESSURE; CARDIOVASCULAR RISK; COLLOIDAL OSMOTIC PRESSURE; CONCENTRATION (PARAMETERS); DIET; DISEASE PREDISPOSITION; ELECTROLYTE EXCRETION; FECES; FRUIT; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GLOMERULUS FILTRATION RATE; HEART DISEASE; HENLE LOOP; HUMAN; HYPERTENSION; KALIURESIS; KIDNEY FAILURE; LOSS OF FUNCTION MUTATION; NATRIURESIS; NEPHRON; NONHUMAN; OSMOTIC PRESSURE; PERCEPTION DEAFNESS; PERITUBULAR ARTERIOLE; PRIORITY JOURNAL; RACE DIFFERENCE; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM ABSORPTION; SODIUM EXCRETION; SODIUM INTAKE; STROKE; SWEAT; URINARY EXCRETION; VEGETABLE; WATER RETENTION;

ANIMALS; BLOOD PRESSURE; HUMANS; HYPERTENSION; LOOP OF HENLE; SODIUM;

EID: 79955466294     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.120246     Document Type: Review

References (87)

1. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303: 2043-2050.
2. Guyton AC, Coleman TG. Regulation on interstitial fluid volume and pressure. Ann NY Acad Sci. 1968;150:537-547.
3. Hall JE, Mizelle L, Hildebrandt DA, Brands MW. Abnormal pressure natriuresis: a cause or consequence of hypertension? Hypertension. 1990; 15:547-559. (Pubitemid 20187599)
4. Hebert SC, Andreoli TE. Control of NaCl transport in the thick ascending limb. Am J Physiol. 1984;246:F745-F756. (Pubitemid 14075683)
5. Bartter FC, Pronove P, Gill JR, MacCardle RC. Hyperplasia of the jutaglomerular complex wih hyperaldosteronism and hypokalemic alkalosis. Am JMed. 1962;33:811-828.
6. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet. 1996;13:183-188.
7. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, Rodriguez-Soriano J, Morales JM, Sanjad SA, Taylor CM, Pilz D, Brem A, Tra-chtman H, Griswold W, Richard GA, Jonh E, Lifton RP. Mutations in the chloride channel gene, ClCNKB, cause Bartter's syndrome type III. Nat Genet. 1997;17:171-178. (Pubitemid 27425949)
8. + channel, ROMK. Nat Genet. 1996;14:152-156. (Pubitemid 26338794)
9. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet. 2002;360: 692-694. (Pubitemid 35232341)
10. Birkenhager R, Otto E, Schurmann MJ, Vollmer M, Ruf EM, Maier-Lutz I, Beekmann F, Fekete A, Omran H, Feldmann D, Milford DV, Jeck N, Konrad M, Landau D, Knoers NV, Antignac C, Sudbrak R, Kispert A, Hildebrandt F. Mutation of BSND causes Bartter syndrome with senso-rineural deafness and kidney failure. Nat Genet. 2001;29:310-314. (Pubitemid 33096457)
11. Brown EM, Pollak M, Seidman CE, Seidman JG, Chou YHW, Riccardi D, Hebert SC. Calcium-sensing cell-surface receptors. N Eng J Med. 1995;333:234-240.
12. (2+)-sensing receptor in divalent mineral ion homeostasis. J Exp Biol. 1997;200:295-302. (Pubitemid 27126460)
13. Huang C, Miller RT. Regulation of renal ion transport by the calcium-sensing receptor: an update. Curr Opin Nephrol Hypertens. 2007;16: 437-443. (Pubitemid 47254694)
14. Garcia NH, Plato CF, Stoos BA, Garvin JL. Nitric oxide-induced inhi-bition of transport by thick ascending limbs from Dahl salt-sensitive rats. Hypertension. 1999;34:508-513. (Pubitemid 29426772)
15. Garvin JL, Herrera M, Ortiz PA. Regulation of renal NaCl transport by nitric oxide, endothelin, and ATP: clinical implications. Ann Rev Physiol. 2010;73:359-376.
16. Herrera M, Ortiz PA, Garvin JL. Regulation of thick ascending limb transport: role of nitric oxide. Am J Physiol Renal Physiol. 2006;290: F1279-F1284. (Pubitemid 43830750)
17. Silva GB, Ortiz PA, Hong NJ, Garvin JL. Superoxide stimulates NaCl absorption in the thick ascending limb via activation of protein kinase C. Hypertension. 2006;48:467-472. (Pubitemid 44253742)
18. Herrera M, Garvin JL. Angiotensin II stimulates thick ascending limb NO production via AT(2) receptors and Akt1-dependent nitric-oxide synthase 3 (NOS3) activation. J Biol Chem. 2010;285:14932-14940.
19. Kim GH, Ecelbarger CA, Mitchell C, Packer RK, Wade JB, Knepper MA. Vasopressin increases Na-K-2Cl cotransporter expression in thick ascending limb of Henle's loop. Am J Physiol. 1999;276:F96-F103. (Pubitemid 29061730)
20. Ito O, Roman RJ. Role of 20-HETE in elevating chloride transport in the thick ascending limb of Dahl SS/JR rats. Hypertension. 1999;33: 419-423. (Pubitemid 29065695)
21. Cowley AW Jr. Renal medullary oxidative stress, pressure-natriuresis, and hypertension. Hypertension. 2008;52:777-786.
22. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003; 290:199-206. (Pubitemid 37430058)
23. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982; 306:1276-1279. (Pubitemid 12100210)
24. Weinberger MH. Salt sensitivity of blood pressure in humans. Hyper-tension. 1996;27:481-490. (Pubitemid 26084617)
25. Weinberger MH, Luft FC, Bloch R, Henry DP, Pratt JH, Weyman AE, Rankin LI, Murray RH, Willis LR, Grim CE. The blood pressure-raising effects of high dietary sodium intake: racial differences and the role of potassium. J Amer College Nutrition. 1982;1:139-148.
26. Pratt JH, Jones JJ, Miller JZ, Wagner MA, Fineberg NS. Racial dif-ferences in aldosterone excretion and plasma aldosterone concentrations in children. N Engl J Med. 1989;321:1152-1157. (Pubitemid 19255810)
27. Pratt JH, Ambrosius WT, Agarwal R, Eckert GJ, Newman S. Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension. 2002;40:903-908. (Pubitemid 35434914)
28. Grim CE, Luft FC, Miller JZ, Meneely GR, Battarbee HD, Hames CG, Dahl LK. Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chron Dis. 1979;33:87-94. (Pubitemid 10213000)
29. Watson RL, Langford HG, Abernethy J, Barnes TY, Watson MJ. Urinary electrolytes, body weight, and blood pressure: pooled cross-sectional results among four groups of adolescent females. Hypertension. 1980;2: I-93-I-98.
30. Berenson GS, Voors AW, Dalferes ER Jr, Webber LS, Shuler SE. Cre-atinine clearance, electrolytes, and plasma renin activity related to the blood pressure of white and black children: the Bogalusa Heart Study. J Lab Clin Med. 1979;93:535-548. (Pubitemid 10210580)
31. Chun TY, Bankir L, Eckert GJ, Bichet DG, Saha C, Zaidi SA, Wagner MA, Pratt JH. Ethnic differences in renal responses to furosemide. Hypertension. 2008;52:241-248
32. Panel on Dietary Reference Intakes for Electrolytes and Water, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Institutes of Medicine of the National Academies. Dietary References Intake for Water, Potassium, Sodium, Chloride, and Sulfate. Washington, DC: National Academies, Press; 2004:186-268.
33. Turban S, Miller ER III, Ange B, Appel LJ. Racial differences in urinary potassium excretion. JAm Soc Nephrol. 2008;19:1396-1402.
34. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure: DASH collaborative research group. N Eng J Med. 1997;336:1117-1124.
35. Palacios C, Wigertz K, Martin BR, Braun M, Pratt JH, Peacock M, Weaver CM. Racial differences in potassium homeostasis in response to differences in dietary sodium in girls. Am J Clin Nutr. 2010;91:597-603.
36. Luft FC, Rankin LI, Bloch R, Weyman AE, Willis LR, Murray RH, Grim CE, Weinberger MH. Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation. 1979;60: 697-706. (Pubitemid 9254074)
37. Pratt JH, Manatunga AK, Bloem LJ, Wei L. Racial differences in aldo-sterone excretion: a longitudinal study in children. J Clin Endocrinol Metab. 1993;77:1512-1515. (Pubitemid 24000905)
38. Pratt JH. Role of angiotensin II in potassium-mediated stimulation of aldosterone secretion in the dog. J Clin Invest. 1982;70:667-672. (Pubitemid 12054593)
39. Pratt JH, Rothrock JK, Dominguez JH. Evidence that angiotensin II and potassium collaborate to increase cytosolic calcium and stimulate secretion of aldosterone. Endocrinology. 1989;125:2463-2469. (Pubitemid 19279432)
40. Rocha AS, Magaldi JB, Kokko JP. Calcium and phosphate transport in isolated segments of rabbitHenle's loop. J ClinInvest. 1977;59:975-983. (Pubitemid 8096350)
41. Suki WN, Rouse D, Ng RC, Kokko JP. Calcium transport in the thick ascending limb of Henle: heterogeneity of function in the medullary and cortical segments. J Clin Invest. 1980;66:1004-1009. (Pubitemid 11233801)
42. Bouby N, Trinh-Trang-Tan MM, Bankir L. Stimulation of tubular reab-sorption of magnesium and calcium by antidiuretic hormone in conscious rats: study in Brattleboro rats with hereditary hypothalamic diabetes insipidus. Pflugers Arch. 1984;402:458-464. (Pubitemid 15221934)
43. Pratt JH, Manatunga AK, Peacock M. A comparison of the urinary excretion of bone resorptive products in white and black children. J Lab Clin Med. 1996;127:67-70.
44. Palacios C, Wigertz K, Martin BR, Jackman L, Pratt JH, Peacock M, McCabe G, Weaver CM. Sodium retention in black and white female adolescents in response to salt intake. J Clin Endocrinol Metab. 2004; 89:1858-1863. (Pubitemid 38507945)
45. Wigertz K, Palacios C, Jackman LA, Martin BR, McCabe LD, McCabe GP, Peacock M, Pratt JH, Weaver CM. Racial differences in calcium retention in response to dietary salt in adolescent girls. Am J Clin Nutr. 2005;81:845-850. (Pubitemid 41724993)
46. Abrams SA, O'Brien KO, Liang LK, Stuff JE. Differences in calcium absorption and kinetics between black and white girls aged 5-16 years. J Bone Miner Res. 1995;10:829-833.
47. Bankir L, Perucca J, Weinberger MH. Ethnic differences in urine con-centration: possible relationship to blood pressure. Clin J Am Soc Nephrol. 2007;2:304-312.
48. Perucca J, Bouby N, Valeix P, Bankir L. Sex difference in urine concen-tration across differing ages, sodium intake, and level of kidney disease. Am J Physiol Regul Integr Comp Physiol. 2007;292:R700-R705. (Pubitemid 46207719)
49. Bakris G, Bursztyn M, Gavras I, Bresnahan M, Gavras H. Role of vasopressin in essential hypertension: racial differences. J Hypertens. 1997;15:545-550. (Pubitemid 27216014)
50. Bursztyn M, Bresnahan M, Gavras I, Gavras H. Pressor hormones in elderly hypertensive persons: racial differences. Hypertension. 1990;15: I88-I92.
51. Cowley AW Jr, Skelton MM, Velasquez MT. Sex differences in the endocrine predictors of essential hypertension: vasopressin versus renin. Hypertension. 1985;7:I151-I160.
52. Hancock ML II, Bichet DG, Eckert GJ, Bankir L, Wagner MA, Pratt JH. Race, sex and the regulation of urine osmolality-observations made during water deprivation. Am J Physiol Regul Integr Comp Physiol. 2010;299:R977-R980.
53. Weder AB, Gleiberman L, Sachdeva A. Whites excrete a water load more rapidly than blacks. Hypertension. 2009;53:715-718.
54. Aviv A, Hollenberg NK, Weder A. Urinary potassium excretion and sodium sensitivity in blacks. Hypertension. 2004;43:707-713. (Pubitemid 38405572)
55. Aviv A, Hollenberg NK, Weder AB. Sodium glomerulopathy: tubuloglo-merular feedback and renal injury in African Americans. Kidney Int. 2004;65:361-368. (Pubitemid 38130630)
56. Bochud M, Staessen JA, Maillard M, Mazeko MJ, Kuznetsova T, Woodiwiss A, Richart T, Norton G, Thijs L, Elston R, Burnier M. Ethnic differences in proximal and distal tubular sodium reabsorption are her-itable in black and white populations. J Hypertens. 2009;27:606-612.
57. Maril N, Rosen Y, Reynolds GH, Ivanishev A, Ngo L, Lenkinski RE. Sodium MRI of the human kidney at 3 Tesla. Magn Reson Med. 2006; 56:1229-1234. (Pubitemid 44865304)
58. Alvarez-Guerra M, Garay RP. Renal Na-K-Cl cotransporter NKCC2 in Dahl salt-sensitive rats. J Hypertens. 2002;20:721-727. (Pubitemid 34913717)
59. + fluxes in membrane vesicles from kidneys of normotensive and hypertensive rats. Biochim Biophys Acta. 1990;1021:13-20. (Pubitemid 20046999)
60. Lifton RP. Molecular genetics of human blood pressure variation. Science. 1996;272:676-680. (Pubitemid 26000271)
61. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545-556. (Pubitemid 32201949)
62. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. Human hypertension caused by mutations in WNK kinases. Science. 2001;293:1107-1112. (Pubitemid 32758085)
63. Goldstein DB. Common genetic variation and human traits. N Engl J Med. 2009;360:1696-1698.
64. Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, Newton-Cheh C, State MW, Levy D, Lifton RP. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008;40:592-599. (Pubitemid 351601207)
65. Tobin MD, Tomaszewski M, Braund PS, Hajat C, Raleigh SM, Palmer TM, Caulfield M, Burton PR, Samani NJ. Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population. Hypertension. 2008;51:1658-1664.
66. Jung J, Foroud TM, Eckert GJ, Flury-Wetherill L, Edenberg HJ, Xuei X, Zaidi SA, Pratt JH. Association of the calcium-sensing receptor gene with blood pressure and urinary calcium in African-Americans. J Clin Endo-crinol Metab. 2009;94:1042-1048.
67. Kapur K, Johnson T, Beckmann ND, Sehmi J, Tanaka T, Kutalik Z, Styrkarsdottir U, Zhang W, Marek D, Gudbjartsson DF, Milaneschi Y, Holm H, Diiorio A, Waterworth D, Li Y, Singleton AB, Bjornsdottir US, Sigurdsson G, Hernandez DG, Desilva R, Elliott P, Eyjolfsson GI, Guralnik JM, Scott J, Thorsteinsdottir U, Bandinelli S, Chambers J, Stefansson K, Waeber G, Ferrucci L, Kooner JS, Mooser V, Vollenweider P, Beckmann JS, Bochud M, Bergmann S. Genome-wide meta-analysis for serum calcium identifies significantly associated snps near the calcium-sensing receptor (CaSR) gene. PLoS Genet. 2010;6:e1001035.
68. El Hajj FG, Seifter J, Scott J, Brown EM. Calcium-regulated renal calcium handling in healthy men: relationship to sodium handling. J Clin Endocrinol Metab. 1998;83:2366-2372. (Pubitemid 28503029)
69. McCarron DA, Morris CD, Henry HJ, Stanton JL. Blood pressure and nutrient intake in the United States. Science. 1984;224:1392-1398. (Pubitemid 14123336)
70. Bucher HC, Cook RJ, Guyatt GH, Lang JD, Cook DJ, Hatala R, Hunt DL. Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials. JAMA. 1996;275:1016-1022.
71. Allender PS, Cutler JA, Follmann D, Cappuccio FP, Pryer J, Elliott P. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med. 1996;124:825-831. (Pubitemid 26128413)
72. Escalante B, Erlij D, Falck JR, McGiff JC Cytochrome P-450 arachid-onate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am J Physiol. 1994;266:C1775-C1782.
73. +-ATPase activity in the thick ascending loop of Henle. Am J Physiol Regul Integr Comp Physiol. 2007;292:R2400-R2405. (Pubitemid 47080703)
74. Laffer CL, Laniado-Schwartzman M, Wang MH, Nasjletti A, Elijovich F. 20-HETE and furosemide-induced natriuresis in salt-sensitive essential hypertension. Hypertension. 2003;41:703-708. (Pubitemid 36314578)
75. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82:131-185. (Pubitemid 34654217)
76. Gainer JV, Bellamine A, Dawson EP, Womble KE, Grant SW, Wang Y, Cupples LA, Guo CY, Demissie S, O'Donnell CJ, Brown NJ, Waterman MR, Capdevila JH. Functional variant of CYP4A11 20-hydroxyeicosa-tetraenoic acid synthase is associated with essential hypertension. Circu-lation. 2005;111:63-69. (Pubitemid 40070845)
77. Mayer B, Lieb W, Gotz A, Konig IR, Aherrahrou Z, Thiemig A, Holmer S, Hengstenberg C, Doering A, Loewel H, Hense HW, Schunkert H, Erdmann J. Association of theT8590C polymorphism ofCYP4A11 with hypertension in the Monica Augsburg Echocardiographic Substudy. Hypertension. 2005;46:766-771. (Pubitemid 43186751)
78. Laffer CL, Gainer JV, Waterman MR, Capdevila JH, Laniado-Schwartzman M, Nasjletti A, Brown NJ, Elijovich F. The T8590C poly-morphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension. Hypertension. 2008;51:767-772. (Pubitemid 351301533)
79. Gainer JV, Lipkowitz MS, Yu C, Waterman MR, Dawson EP, Capdevila JH, Brown NJ. Association of a CYP4A11 variant and blood pressure in black men. JAm Soc Nephrol. 2008;19:1606-1612.
80. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol. 1996;270:R217-R227.
81. Ward NC, Tsai IJ, Barden A, van Bockxmeer FM, Puddey IB, Hodgson JM, Croft KD. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure. Hypertension. 2008;51:1393-1398. (Pubitemid 351555955)
82. Weinberger MH, Dowdy AJ, Nokes GW, Luetscher JA. Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic J Clin Endocr. 1968;28:359-371.
83. Collins RD, Weinberger MH, Dowdy AJ, Nokes GW, Gonzales CM, Luetscher JA. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity. J Clin Inves. 1970;49:1415-1426.
84. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D. Serum aldosterone and the incidence of Hypertension in nonhypertensive persons. N Engl J Med. 2004;351:33-41.
85. Hadchouel J, Soukaseum C, Busst C, Zhou XO, Baudrie V, Zurrer T, Cambillau M, Elghozi JL, Lifton RP, Loffing J, Jeunemaitre X. Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension. Proc Natl Acad Sci USA. 2010;107: 18109-18114.
86. McDonough AA. Mechanisms of proximal tubule sodium transport reg-ulation that link extracellular fluid volume and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2010;298:R851-R861.
87. Sile S, Velez DR, Gillani NB, Narsia T, Moore JH, George AL Jr, Vanoye CG, Williams SM. CLCNKB-T481S and essential hypertension in a Ghanaian population. J Hypertens. 2009;27:298-304.